The Drug Delivery Technology ecosystem spans upstream raw‑material sourcing, midstream design and manufacturing, and downstream commercialization. Upstream participants supply polymers, lipids, and active pharmaceutical ingredients that define formulation possibilities. Midstream actors—including technology providers, original equipment manufacturers, and system integrators—translate these inputs into scalable devices, embedding release‑control mechanisms, sensing electronics, and patient‑centric interfaces. Downstream channels such as distributors and service firms handle logistics, cold‑chain integrity, and post‑sale support, ultimately delivering finished products to hospitals, pharmacies, and clinics. Value is created when each layer adds functional differentiation or compliance, and captured through licensing fees, device sales, and service contracts. Revenue streams also include royalty arrangements for patented delivery platforms and data licensing from connected devices. The configuration of these links determines speed to market and the ability to monetize innovation.